MMI - Medical Microinstruments, Inc.

MMI - Medical Microinstruments, Inc.

is a privately held medical device company founded in 2015 near Pisa, Italy. The company specializes in robotic microsurgery, providing surgeons with advanced tools to perform complex micro-level procedures with enhanced precision and control. MMI operates primarily from its headquarters in Pisa and its North American office in Jacksonville, Florida, employing around 200 people globally. The flagship product, the Symani® Surgical System, is the only commercially available robotic platform designed for microsurgical precision. It features the world’s smallest wristed instruments, tremor reduction technology, and motion scaling capabilities. The system is FDA authorized in the U.S. and CE marked in Europe, enabling surgeons to address complex procedures in microvascular, lymphatic, and nerve repair. MMI's technology supports specialized surgeons in treating conditions such as breast cancer reconstruction, lymphedema, and trauma surgery.